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This is the report on tuberculosis (TB) control for the WHO Western Pacific Region. It includes data
on estimates of disease burden, case notifications and treatment outcomes reported from 36 of 37
countries and areas in the Region in 2004. Regionally, tuberculosis remains a major public health
problem. In 2004, there were an estimated 3.8 million prevalent cases of TB (216 per 100 000
population) in the Region, of which almost 2 million were new cases (111 per 100 000 population).
Three countries (China, the Philippines and Viet Nam) accounted for about 90% of the total estimated
new cases in the Region. China accounted for 70% of incident TB cases (all forms) in the Region.
The human immunodeficiency virus (HIV) epidemic has had an impact in the Region:  the prevalence
of HIV among TB cases was 13% in Cambodia, 3.7% in Papua New Guinea and 3% in Viet Nam. In
addition, drug resistance was found in all settings surveyed in the Region; the prevalence of multidrug
resistant-tuberculosis (MDR-TB) in previously untreated cases varied widely across settings ranging
from 0.1% to 10.4%.
The case detection rate in the Region in 2004 (see Annex 1 for definitions) was 60% for all tuberculosis
cases and 67% for new smear-positive cases. In other words, the 1.2 million notified cases (all
types) represented 60% of the 2 million estimated cases (all types) and the 579 594 notified new
smear-positive cases represented 67% of the estimated new smear-positive cases. Based on
preliminary data, the Region has likely reached the 2005 case detection rate target of 70%.
Case detection rates in areas with directly observed treatment, short-course (DOTS) have been
steadily increasing in the Region since 2002. The 67% increase in case detection in the Region
from 2002 to 2004 is primarily due to a dramatic 110% increase in case detection in China.
In DOTS areas, the treatment cure and success rates were 87% and 91%, respectively, for the
cohort of 426 675 new pulmonary smear-positive cases registered for treatment in 2003. In the
Lao People’s Democratic Republic and Papua New Guinea, two countries with a high burden of
tuberculosis,1 treatment success rate were below the 85% WHO target.
In 2000, the Regional Committee for the Western Pacific endorsed the impact targets of 50% reduction
in prevalence and mortality due to TB within 10 years, by 2010. To achieve the impact targets by
2010, the Region needs to accelerate the rate of decline in prevalence and mortality by further
improving the quality of DOTS services, and by addressing the current challenges of MDR-TB and
HIV.
Executive Summary
1 Seven countries in the Western Pacific Region have a high burden of tuberculosis:  Cambodia, China, the Lao People’s
Democratic Republic, Mongolia, Papua New Guinea, the Philippines and Viet Nam
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The WHO Western Pacific Region covers a broad geographic area comprising more than 27% of
the world’s population, in 37 countries and areas.
In 2005, WHO sent a standard form for reporting surveillance data to all 37 countries and areas.
Information was collected about the number and types of tuberculosis (TB) cases notified in 2004,
on the outcomes of treatment among smear-positive and smear-negative as well as re-treatment
smear-positive cases registered in 2003, and about policies and practices in use for TB control. In
addition, data from drug resistance and TB-HIV surveillance were compiled.
Over a decade ago, WHO declared tuberculosis a “global emergency”, not only because of its
effect on individuals but also because of its wider social and economic ramifications on a country’s
development. Targets were established to measure the progress of implementation of the directly
observed treatment, short-course (DOTS) strategy to combat tuberculosis by 2005. These targets
include 100% population coverage with DOTS, 70% case detection and 85% treatment success
rate. Achieving these targets is an important intermediate step towards reaching the impact targets
of 50% reduction in prevalence and mortality due to TB by 2010, compared with 2000. Since 2000,
the Western Pacific Region has achieved significant progress:  DOTS coverage reached 94% at the
end of 2004; the Region has already achieved the cure rate target in DOTS areas; and it will likely
reach the 70% case detection target by the end of 2005.
The Western Pacific Region publishes an annual TB report sharing current knowledge on the state
of TB in the Region. Its primary aim is to present data on TB epidemiology and related information
reported from national TB control programmes (NTP). The annual report highlights the similarities
and differences within the Region and the strategies that have been adopted to address the TB
epidemic.
Introduction1
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Epidemiology2
This report is based on case notifications for 2004 and treatment outcomes for patients registered
in 2003, as reported by national TB control programmes to the World Health Organization in 2005,
using standard data collection forms, with common definitions and variables (Annex 1).
2.1 Estimated burden
Estimates of TB prevalence, incidence and mortality in countries are based on a consultative and
analytical process that takes into account all available information on case notifications; prevalence
of infection and disease; tuberculin surveys; duration of illness; proportion of smear-positive cases;
numbers of cases treated and remaining untreated; HIV prevalence and incidence; mortality and
demography. The estimates of disease burden are revised annually by WHO to reflect new
information gathered through surveillance and from special studies such as prevalence and annual
risk of tuberculosis infection (ARTI) studies conducted in countries. The estimates are also applied
to previous years, retrospectively, when necessary. The estimated figures are WHO provisional
estimates published in the WHO Report 2006: Global Tuberculosis Control. The methodology used
for case estimates was described in detail in the “Global Burden of Tuberculosis,”2 published in
1999, and “The Growing Burden of Tuberculosis,”3 published in 2003. In all measurements of TB
indicators, population estimates provided by the United Nations Population Division are used,4
recognizing that these sometimes differ from population data in the countries themselves (many of
which are based on more recent survey data).
In 2004, there were an estimated 3.8 million prevalent cases of TB (216 per 100 000 population) in
the Western Pacific Region, of which almost 2 million were new cases (111 per 100 000 population).
China accounted for about 70% of all incident TB cases (all forms) in the Region.
It was estimated that 307 411 deaths from tuberculosis occurred in the Region in 2004, i.e. 18
deaths from tuberculosis per 100 000 population.  The death rate from tuberculosis per 100 000
population was highest in Cambodia (94) as compared to 17 in China.
Table 1 shows the rates of change in the estimated prevalence and death rates from 2000 to 2004.
2 Dye C et al. Global Burden of Tuberculosis. Estimated Incidence, Prevalence, and Mortality by Country. Journal of the
American Medical Association , 1999, 282: 677–686.
3 Corbett EL et al. The Growing Burden of Tuberculosis. Global Trends and Interactions with the HIV Epidemic. Archives of
Internal Medicine , 2003, 163(9): 1009–1021.
4 World Population Prospects: The 2004 Revision Population Database.  New York, United Nations Population Division,
2005 (http://esa.un.org/unpp/, accessed January 2006).
TABLE 1:  ESTIMATED PREVALENCE RATES (ALL CASES) AND DEATH RATES PER 100 000 OF
TB IN THE WESTERN PACIFIC REGION
The estimated prevalence and death rates decreased in the Region at an overall yearly rate
of –4.8% and –2.7%, respectively.
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2.2 Case notification
2.2.1 Notifications
The population coverage with DOTS was 94% in the Western Pacific Region in 2004.
The Region detected 25% of the total number of cases detected globally. The Region accounted
for approximately 1.2 million cases of all forms of all notified cases of tuberculosis and 579 594
notified cases of smear-positive tuberculosis in 2004.  The largest number was from China, with
790 603 cases (384 886 smear-positive cases). Thus China alone accounted for 16% of all reported
tuberculosis cases and 17% of all smear-positive cases reported globally.5
2.2.2 Notification rates
The case notification rate per 100 000 population in the Western Pacific Region was 67 for 2004.
The notification rate for all cases in the Region has been steady since 1995. After a slight but
steady decline since 1996, the Region has experienced a more rapid increase in its notification
rate, from 47 to 67 per 100 000 between 2002 and 2004 (Figure 1).
5 Global tuberculosis control - surveillance, planning, financing. Geneva, World Health Organization, 2006 (WHO/HTM/TB/
2006.362).
The smear-positive notification rate for the Western Pacific Region held steady between 1998 and
2002, at 22 per 100 000. Since 2003, the Region has shown a comparative increase in the smear-
positive notification rate, to 33 per 100 000 (Figure 2).
FIGURE 1:  CASE NOTIFICATION RATES (ALL FORMS) IN THE WESTERN PACIFIC REGION,
1995–2004
FIGURE 2: CASE NOTIFICATION RATES OF SMEAR-POSITIVE CASES, 1995–2004
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2.2.3 Age- and sex-specific notification rates
The age- and sex-specific notification rates for the Region for 2004 show that males have higher
rates overall and display an upward trend in the higher age groups, indicating a shift in the
epidemiology of tuberculosis (see Figure 3).
FIGURE 3:  SMEAR-POSITIVE NOTIFICATION RATES, BY AGE AND SEX, 2004
2.3 TB-HIV
The HIV epidemic has reached a generalized stage at the national level in Cambodia and in
Papua New Guinea. The prevalence of HIV infection among TB was estimated to be 13% in
Cambodia and 3.7% in Papua New Guinea in 2004. In other countries affected by HIV,6 particularly
China and Viet Nam, the HIV epidemic is still at the concentrated stage. In China, HIV prevalence
data indicate a concentrated spread of infections among injecting drug users (IDUs) and no
significant spread to the non-IDU population. Although HIV/AIDS cases have been detected in all
provinces, HIV transmission is focused primarily among IDUs in certain provinces. In Viet Nam, the
prevalence is highest among IDUs (24% in 2000), but sexual transmission of HIV is increasing
among female sex workers.
Tuberculosis is the most important life-threatening opportunistic infection associated with HIV.
Table 2 shows the regional estimated prevalence of HIV among TB cases in countries with a high
TB burden. The overall estimated HIV seropositivity among new adult TB cases is 1.4% in the
Western Pacific Region.
6 Global Health Atlas (http://www.who.int/GlobalAtlas/PDFFactory/HIV/index.asp, accessed February 2005).
TABLE 2:  ESTIMATED PREVALENCE OF HIV IN NEW TB CASESa
a Detailed methodology and year 2000 estimates published in: Corbett EL et al. The Growing Burden of Tuberculosis:
Global Trends and Interactions with the HIV Epidemic. Archives of Internal Medicine, 2003, 163(9): 1009–1021.
5
2 | EPIDEMIOLOGY
Tuberculosis Control in the Western Pacific Region: 2006 Report
2.4 Drug resistance
Multidrug resistant-tuberculosis (MDR-TB) is posing a threat to tuberculosis control in several
countries.
In 1994, the Global Project on Anti-tuberculosis Drug Resistance Surveillance was launched by
WHO, the International Union Against TB and Lung Disease (The Union) and several other partners.
The Global Project methodology for drug resistance surveillance was designed around and continues
to operate on three main principles: (1) surveillance must be based on a sample of TB patients
representative of all cases in the geographical setting under evaluation; (2) drug resistance must
be clearly distinguished according to the treatment history of the patient in order to allow correct
interpretation of resistance data; and (3) optimal laboratory performance must be attained through
participation in a quality assurance programme, including the international exchange of strains of
Mycobacterium tuberculosis.
Drug resistance was present in all settings surveyed in the Western Pacific Region. The prevalence
of drug resistance varied widely across settings (Table 3). DOTS-Plus pilot programmes are already
implemented in the Philippines and in Mongolia, and are starting in two provinces of China.
TABLE 3:  ANTI-TUBERCULOSIS DRUG RESISTANCE, BY COUNTRY
aData from Australia are for combined cases.  bINH: Isoniazid; cMDR: multidrug resistance
Continuous monitoring of trends in high prevalence MDR settings is essential in order to assess
current interventions and their impact on the epidemic. To date, it is difficult to interpret trends in
high MDR prevalence settings with any certainty. No area reaching MDR prevalence of 6.5% has
dropped below that point in subsequent surveys, suggesting that, when a critical threshold of
transmission has been reached within a population, it may take a considerable amount of time to
reduce the prevalence of MDR-TB. The results of improved TB control interventions under DOTS,
and targeted interventions such as DOTS-Plus, may not be as rapidly evident in these settings as
they might in a population with a lower prevalence of resistance.
Australia
Cambodia
China
Heilongjiang
Henan
Hubei
Inner Mongolia
Liaoning
Zhejiang
Hong Kong (China)
Malaysia
Mongolia
New Zealand
Republic of Korea
Singapore
Viet Nam
2001
2001
2004
2001
1999
2003
1999
1998
2001
1996
1999
2001
1998
2001
1996
770
638
1574
1222
859
806
818
802
3470
1001
405
272
2370
823
640
5.6
4.7
4.9
3.3
3.7
5.0
5.4
2.7
2.3
1.0
4.4
4.4
4.9
1.6
6.7
9.9
10.3
36.1
29.8
17.5
35.0
42.1
14.8
10.2
4.8
29.4
11.4
10.6
5.0
32.5
1.6
0.0
7.2
7.8
2.1
7.3
10.4
4.5
0.8
0.1
1.0
0.0
2.2
0.5
2.3
96
421
265
238
308
86
140
169
16
-
22
283
126
-
3.1
30.4
36.6
21.8
41.9
24.4
35.0
11.2
0.0
-
0.0
7.1
0.8
-
New casesa Previouslytreated cases
Year Numbers
INHb
resistance
Any
resistance MDR
c Numbers MDR
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Progress in TB control3
3.1 DOTS coverage
Among the 37 countries and areas in the Western Pacific Region, all have had at least part of their
population covered by DOTS units. Figure 4 shows the DOTS population coverage achieved between
1995 and 2004.
FIGURE 4:  DOTS COVERAGE IN THE WESTERN PACIFIC REGION, 1995-2004
Much of the increase in population coverage in recent years is attributable to DOTS expansion in
China.
3.2 Case detection
The overall case detection rate (DOTS and non-DOTS) was 60% for all tuberculosis and 67% for
smear-positive cases (Table 4); DOTS areas reported 65% of all estimated new smear-positive
cases. Case detection has increased 29% between 2003 and 2004 in the Region.
TABLE 4: CASE DETECTION RATES OF SMEAR-POSITIVE CASES IN 2004
Western Pacific Region
Cambodia
China
Lao People's Democratic Republic
Mongolia
Papua New Guinea
Philippines
Viet Nam
67
61
65
55
80
31
73
89
29
2
44
17
18
-43
7
3
Smear-positive cases (%) % Increase (from 2003 to 2004)
Case detection rates
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Case detection made steady but slow progress in the Western Pacific Region until 2002. The increase
in case detection (+29%) in the Region between 2003 and 2004 is mostly due to a dramatic increase
in case detection in China (+44%). The global target of 70% case detection rate by the end of 2005
has likely been reached in the Region (Figure 5).
Note: The forecast line for the Western Pacific Region is based on preliminary data from 2005 (Q-DOTS quarterly reporting
to WHO).
3.3 DOTS enrolment and progress in overall case detection
Figure 6 shows trends in new smear-positive case detection rates in DOTS and non-DOTS areas in
the Region during the period 1995 to 2004. Regionally, the total case detection rate was stable
from 1997 to 2002, although there was rapid DOTS expansion during this period and rapid increase
to 2004.
FIGURE 6:  TRENDS IN DOTS AND NON-DOTS CASE DETECTION RATES (NEW SMEAR-POSITIVE
CASES) IN THE WESTERN PACIFIC REGION
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FIGURE 5:  TRENDS IN DOTS CASE DETECTION RATES OF SMEAR-POSITIVE CASES, 1995-2004
3.4 Treatment outcomes
Regionally, in DOTS areas, the cure and treatment success rates were 87% and 91%, respectively,
for the cohort of 426 675 new pulmonary smear-positive cases registered for treatment in 2003. The
regional TB control programme has reached the target of 85% cure rate. It is notable that reported
failure rates in both DOTS (1%) and non-DOTS (1%) areas are very low (Figure 7).
FIGURE 7:  TREATMENT OUTCOMES FOR NEW SMEAR-POSITIVE CASES REGISTERED IN 2003
IN DOTS AND NON-DOTS AREAS IN THE WESTERN PACIFIC REGION
FIGURE 8:  TREATMENT OUTCOMES FOR NEW SMEAR-POSITIVE CASES REGISTERED IN 2003
IN DOTS AREAS IN HIGH-BURDEN COUNTRIES
In total, 15 countries and areas out of 36 reported
treatment outcomes below the 85% global
target, including two countries with a high
burden of TB - The Lao People's Democratic
Republic and Papua New Guinea (Figure 8).
Non-DOTS areas reported a lower success rate
for treatment completion than DOTS areas.
Figure 9 shows the distribution of unfavourable
outcomes in the Region. Defaults (25%) and
deaths (25%) together accounted for half of all
unfavourable outcomes among new smear-
positive TB cases registered under DOTS
programmes in the Western Pacific Region in
2003.
9
3 | PROGRESS IN TB CONTROL
FIGURE 9:  UNFAVOURABLE OUTCOMES
AMONG NEW SMEAR-POSITIVE CASES
REGISTERED IN 2003 IN DOTS AREAS IN THE
WESTERN PACIFIC REGION
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3.5 Treatment results of re-treatment cases
Figure 10 shows treatment outcomes for re-treatment cases in the Western Pacific Region. The
high success rate among re-treatment cases in China accounted for the overall high treatment
success rate (87%) among re-treatment cases in the Western Pacific Region.
FIGURE 10:  TREATMENT OUTCOMES FOR
RE-TREATMENT CASES REGISTERED IN 2003
(DOTS AREAS)
3 | PROGRESS IN TB CONTROL
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Explanatory notes7
Regional summary and country data are presented in the following 12 tables.  All rates are per
100 000 population.
Table 5
Estimated burden of TB, 2000 and 2004
Estimates of incidence, prevalence and mortality for 2000 (baseline year for impact targets endorsed
by the Regional Committee) and 2004 (the latest year covered by this report). See Annexes 2 and
3 for details of calculations. All estimates include TB in people living with HIV.
Table 6
Whole country case notifications and case detection rates, 2004
Case notifications by history (new or re-treatment), by site (pulmonary or extrapulmonary) and by
smear status (smear-positive, smear-negative or unknown). Proportions of case types and estimated
case detection rate for whole country (DOTS and non-DOTS combined).
• Population, source:  World population prospects – the 2004 revision. New York; United Nations
Population Division, 2005.
• Country total:  the total number of TB cases according to the country’s own reporting convention
(in many countries this matches the WHO total – new and relapse; other countries include re-
treatment cases and/or cases with unknown treatment history).
• WHO total: new and relapse cases.
• Other new: new cases for which the site of disease is not recorded.
• Other retreat: re-treatment cases for which the outcome of previous treatment is not known.
• Other: cases for which neither treatment history nor site of disease is recorded.
• New pulm. lab. confirmed: new pulmonary cases in which diagnosis has been confirmed by
smear and/or culture examination.
• Detection rate, all cases: notified (new and relapse) cases divided by estimated incident cases
(expressed as a percentage).
• Detection rate, new SS+: notified new smear-positive cases divided by estimated incident
smear-positive cases (expressed as a percentage).
• SS+ (% of pulm.):  the percentage of all new pulmonary cases that are smear-positive.
• SS+ (% of new+relapse):  the percentage of new and relapse case that are new smear-positive.
• Extrapulm. (% of new+relapse): the percentage of all new and relapse cases that are
extrapulmonary.
• Retreat. (% of new+retreat.): notified re-treatment cases as a percentage of all notified cases.
Table 7
DOTS coverage, case notifications and case detection rates, 2004
• DOTS coverage: the percentage of the national population living in areas where health services
have adopted DOTS.
7 See Global tuberculosis control - surveillance, planning, financing. Geneva, World Health Organization, 2006 (WHO/HTM/
TB/2006.362).
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Table 8
Public–Public and Public–Private Mix (PPM), collaborative TB-HIV activities and management
of MDR-TB, 2003–2004
Public–Public and Public–Private Mix (PPM)
• Guidelines for other practitioners:
— In the final row of the data table, numbers represent the proportion of countries in the
Region that have guidelines for management of TB for practitioners working outside public
health clinics.
— “Yes” or “No” indicates whether guidelines for TB management are available for practitioners
working outside public health clinics.
• Institutions notifying NTP:
— In the final row of the data table, the numbers represent the proportion of countries in the
Region where at least some providers of a particular type notified TB cases to the NTP in
2004.
— “All”, “Some” or “None” indicates whether any providers of a particular type notified TB
cases to the NTP in 2004.
Collaborative TB-HIV activities
• HIV testing for TB patients (pts):
— In the final row of the data table, the numbers represent the proportion of countries in the
Region that implemented, at least partially, a national policy of offering HIV testing and
counselling to TB pts.
— “Yes” indicates that the country implemented a national policy of offering HIV testing and
counselling to all TB patients in 2004; “Partially” indicates that the policy was implemented
in part of the country.
• HIV surveillance among TB pts:
— In the final row of the data table, the numbers represent the proportion of countries in the
Region that have a national system for HIV surveillance among TB patients.
— “Yes” or “No” indicates whether the country has a national system for HIV surveillance
among TB patients.
• TB pts tested for HIV: the number of TB patients tested for HIV in 2003.
• TB pts HIV-positive: the number of TB patients found to be HIV-positive in 2003.
• TB pts CPT: the number of HIV-positive TB patients given co-trimoxazole preventive therapy in
2003.
• TB pts ART: the number of HIV-positive TB patients given antiretroviral therapy during their TB
treatment in 2003.
Multidrug resistant-TB
• Laboratory-confirmed MDR: number of laboratory-confirmed cases of MDR-TB identified among
TB patients diagnosed in 2004.
• DST in new cases: number of new TB cases in 2004 for which drug sensitivity testing (DST)
was performed at start of treatment.
• MDR in new cases: number of new cases identified as MDR-TB based on DST at start of
treatment.
• Re-treatment DST: number of re-treatment cases registered in 2004 for which DST was performed
at start of treatment.
• Re-treatment MDR: number of re-treatment cases identified as MDR-TB.
Table 9
Treatment outcomes, 2003 cohort
Treatment outcomes of new smear-positive cases treated under DOTS, non-DOTS and re-treatment
cases under DOTS.
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Table 10
Re-treatment outcomes, 2003 cohort
Re-treatment outcomes of smear-positive cases treated under DOTS after relapse, treatment failure
or default.
Table 11
DOTS treatment success and case detection rates, 1994–2004
Treatment success rates (the proportion of registered cases cured or completed treatment) for new
smear-positive cases treated under DOTS from 1994 to 2003 and smear-positive case detection
rates under DOTS from 1995 to 2004.
Table 12
New smear-positive case notification by age and sex, absolute numbers, DOTS and non-
DOTS, 2004
Breakdown by age and sex of new smear-positive cases notified from whole country (DOTS and
non-DOTS). Some countries cannot provide the breakdown for all smear-positive notified cases.
Table 13
New smear-positive case notification rates by age and sex, DOTS and non-DOTS, 2004
Notification rates of new smear-positive cases by age and sex (DOTS + non-DOTS). Rates are
missing where breakdown of smear-positive notified cases is not provided, or when age- and sex-
specific population data are not available.
In the regional summary row, rates exclude those countries for which breakdown of notified cases
or population by age and sex is missing.
Table 14
Number of TB cases notified, 1980–2004
Table 15
Case notification rates, 1980–2004
Table 16
New smear-positive cases notified, numbers and rates, 1993–2004
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TABLE 5: ESTIMATED BURDEN OF TB, 2000 AND 2004
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Incidence, 2000 Prevalence, 2000 TB mortality, 2000
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
All formsa All forms
HIV+
Smear-
positivea
Smear-positive
HIV+
All formsa All forms
HIV+
All formsa All forms
HIV+
Incidence, 2004 Prevalence, 2004 TB mortality, 2004
All formsa All forms
HIV+
Smear-
positivea
Smear-positive
HIV+
All formsa All forms
HIV+
All formsa All forms
HIV+
a Incidence, prevalence and mortality estimates include patients with HIV. Estimates labelled "HIV+" are estimates of TB in HIV-positive adults (ages 15-49 years). Estimates for all years are recalculated as new information
becomes available and techniques are refined, so may differ from those published previously.
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TB cases notified from whole country (DOTS + non-DOTS) Incidence and case detection rates Proportions
Population,
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TABLE 6: WHOLE COUNTRY CASE NOTIFICATIONS AND CASE DETECTION RATES, 2004
(SS+) — sputum smear-positive; (SS–) — sputum smear-negative; unk. — sputum smear result unknown; retreat. — re-treatment; pulm. lab. confirmed — pulmonary case confirmed by positive smear or culture. See Explanatory
notes for further details. Data can be downloaded from http://stoptb.wpro.who.int.
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TABLE 7: DOTS COVERAGE, CASE NOTIFICATIONS AND CASE DETECTION RATES, 2004
(SS+) — sputum smear-positive; (SS–) — sputum smear-negative; unk.— sputum smear result unknown; retreat. — re-treatment; pulm. lab. confirmed — pulmonary case confirmed by positive smear or culture. See Explanatory
notes for further details. Data can be downloaded from http://stoptb.wpro.who.int.
TB cases reported from DOTS services Incidence and case detection rates Proportions
DOTS
coverage
%
New and relapse
(WHO total) New extra-
pulmonary
number
Other
new
number
New pulmonary Re-treatment cases
Other
number
New pulm.
lab.
confirm.
number
Estimated incidence Case detection rate
SS+
(% of
pulm.)
SS+
(% of
new+
relapse)
Extra
pulm. (%
of new+
relapse)
Retreat.
(% of
new+
retreat.)Number Rate Number Rate
SS+
SS- / unk.
number
Relapse
number
After
failure
number
After
default
number
Other
retreat.
number
all forms
number
SS+
number
new and
relapse %
new SS+
%
American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
100
63
100
100
96
98
100
100
100
100
71
100
98
100
100
100
90
100
100
100
100
100
95
47
100
100
100
100
100
100
94
5
655
176
30 838
763 035
1
134
60
51
4579
21 755
310
3173
323
14 986
119
118
4570
61
373
0
53
5
8751
130 530
12 357
1516
340
115
98 389
1 097 378
8
3
48
223
58
6
16
24
31
66
17
318
55
71
60
199
108
175
26
9
0
67
25
152
160
26
35
73
55
118
63
2
168
115
18 978
377 546
1
62
30
22
1290
7572
142
2,241
128
7843
39
35
1808
15
112
0
14
5
1151
78 163
4044
506
152
59
58 389
560 632
3
1
31
138
29
6
7
12
13
19
6
146
39
28
32
65
32
69
6
3
0
18
25
20
96
8
12
33
28
70
32
1
236
15
5800
269 226
0
38
12
9
2271
9129
59
472
129
5136
38
51
866
14
86
0
34
0
3959
47 937
6680
660
107
32
17 106
370 103
2
231
38
5415
37 566
0
31
9
10
501
4278
107
343
38
1543
37
26
1718
30
129
0
5
0
3396
1275
127
182
68
23
16 218
73 346
0
0
0
8
0
0
0
0
0
0
37
0
0
0
0
0
0
45
0
20
8
645
78 697
0
3
9
2
517
776
2
117
28
464
5
6
178
2
9
0
0
0
245
3155
1506
168
13
1
6676
93 252
0
0
41
0
0
0
3
1
15
0
27
0
53
0
0
0
79
4
0
2
522
750
0
1
29
0
0
0
43
0
52
3
357
2
16
33
0
0
0
344
22
0
0
251
1153
0
6
197
85 409
0
0
0
49
0
0
3
59
1
3
5
0
0
0
1010
0
0
86 742
0
5
9
7592
0
0
2
0
0
43
5
0
0
0
0
0
1550
12
0
9218
2
351
120
18 978
377 546
1
62
30
30
2636
11 527
142
2241
207
7843
39
69
1808
24
176
0
24
5
1151
78 163
5126
892
152
59
58 389
567 793
18
1132
197
70 370
1 324 633
5
239
72
98
5223
37 814
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11 449
16
29
2257
2
62
191
0
21
5
6025
107 738
19 339
24
757
123
0
13
1
55
65 745
2
864 745
28
58
89
44
58
19
56
84
52
88
58
540
35
87
59
338
183
91
45
88
0
114
43
65
55
29
90
124
94
67
57
25
33
129
61
63
43
58
93
50
55
45
550
55
76
69
246
120
80
24
59
0
67
95
19
73
21
67
123
107
89
65
4
5
3
19
2
15
4
13
4
1
6
10
6
7
18
6
3
4
3
2
21
12
4
3
8
15
40
35
22
18
5
23
15
20
11
20
35
11
12
10
31
22
38
49
35
9
39
1
1
12
20
20
16
7
40
26
65
62
49
100
46
50
43
28
35
46
71
40
52
33
30
40
25
30
26
100
13
60
33
33
45
51
59
51
67
42
88
77
58
100
62
71
71
36
45
71
83
50
60
51
41
68
52
57
29
100
23
62
38
43
59
65
77
60
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TABLE 8: PUBLIC-PUBLIC AND PUBLIC-PRIVATE MIX (PPM), COLLABORATIVE TB-HIV ACTIVITIES AND MANAGEMENT OF MDR-TB, 2003-2004
ART — antiretroviral therapy; CPT — co-trimoxazole preventive therapy; pts — patients; DST — Drug susceptibility testing; MDR — Multidrug resistance. The regional row for the first nine columns represents the proportion of
countries that provided an affirmative response ("Yes", "All", "Some" or "Partially"). See Explanatory notes on page 12 for further details. Some countries provided the number of TB patients found to be HIV-positive, but did not
provide the number of TB patients tested. The regional total of TB patients tested is therefore lower than the number of patients actually tested, and cannot be used to calculated a regional estimate of HIV prevalence in TB patients.
Data can be downloaded from http://stoptb.wpro.who.int.
American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
TB cases reported from DOTS services Collaborative TB-HIV activities, 2003 or 2004 Multidrug-resistant TB, 2004
Guidelines
for other
practitioners
Private
hospitals or
clinics
Private
practitioners
Public
hospitals
Prisons Military Insurance
Institutions notifying NTP HIV
testing for
TB pts
HIV
surveillance
among TB
pts
TB pts
tested
for HIV
number
TB pts
HIV-positive
number
TB pts
CPT
number
TB pts
ART
number
Laboratory-
confirmed
MDR
number
DST
in new cases
number
MDR in
new cases
number
Re-treatment
DST
number
Re-treatment
MDR
number
Yes
No
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
No
No
Yes
No
Yes
No
No
50
No
All
All
Some
Some
All
All
All
All
All
No
No
Some
Some
No
No
All
All
All
All
No
Some
All
All
Some
No
53
No
All
All
No
Some
All
All
All
All
All
No
No
Some
Some
No
No
All
All
All
All
No
Some
All
All
Some
No
50
No
All
All
All
Some
All
All
All
All
All
All
All
Some
All
All
All
All
Some
All
All
All
All
All
Some
All
All
All
No
72
No
All
All
No
Some
All
All
All
All
Some
Some
No
All
Some
No
Some
All
All
All
All
All
Some
Some
All
No
No
56
Some
All
Some
Some
All
All
All
All
No
All
No
All
No
Some
All
All
No
All
Some
Some
All
No
No
47
Some
All
No
Some
All
All
All
No
No
No
No
No
No
No
No
All
All
No
No
Some
No
All
No
No
28
No
Partially
Yes
No
No
No
Partially
Yes
Yes
Yes
No
Yes
Partially
Yes
Yes
Partially
Partially
No
Yes
No
Yes
Yes
No
No
No
No
No
No
No
42
No
No
Yes
No
No
No
No
Yes
Yes
Yes
No
No
Yes
Yes
Yes
No
No
No
Yes
No
Yes
Yes
Yes
No
No
No
No
No
No
No
31
0
190
0
122
17
12
3122
0
361
15 316
0
8
510
16
141
53
4
19 872
12
1
0
4
0
0
2
0
1
1263
0
0
0
0
2
0
0
1285
0
0
0
0
15
0
0
0
0
0
0
0
15
1
0
0
0
9
0
1
0
0
0
0
0
0
11
0
12
0
0
5
0
0
35
0
0
8
0
2
1
1
0
3
0
1
0
0
230
110
2
410
0
12
181
0
59
51
29
3566
0
0
207
0
26
28
8
2
278
0
5
1
0
269
2636
838
8196
0
5
0
0
4
0
0
16
0
0
5
0
2
1
4
0
3
0
1
0
0
2
71
2
116
0
5
0
0
1
11
0
513
0
0
22
0
8
4
40
10
0
0
0
0
278
117
1009
0
2
0
0
1
0
0
19
0
0
2
0
2
1
14
0
0
0
0
0
0
39
0
80
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TABLE 9: TREATMENT OUTCOMES, 2003 COHORT
Not eval. — not evaluated (percentage of registered cases for which outcomes were not recorded); success — sum of cured and completed; cases regist'd — the denominator for calculating treatment outcomes. The number of
cases registered for treatment in 2003 is the denominator for calculating treatment outcomes unless it is less than the sum of outcomes, in which case the sum of outcomes is used. If the number of cases registered is not reported,
then the number of cases notified in 2003 is used, or the sum of outcomes if the latter is greater. Data can be downloaded from http://stoptb.wpro.who.int.
American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
New smear-positive cases, DOTS
Number
of cases
Notified Regist'd
% of cohort
%
of notif
regist'd Cured
Compl-
eted
Died Failed Default
Trans-
ferred
Not
eval.
%
Success
Number
of cases
Notified Regist'd
% of cohort
%
of notif
regist'd Cured
Compl-
eted
Died Failed Default
Trans-
ferred
Not
eval.
%
Success
New smear-positive cases, non-DOTS Smear-positive re-treatment cases, DOTS
Number
Regist'd
% of cohort
%
Success
Cured
Compl-
eted
Died Failed Default
Trans-
ferred
Not
eval.
63
19 942
366
13 798
1 307 989
18
841
253
167
6963
127 923
97
5792
457
24 894
60
110
2614
13
233
3989
1
79
20
5772
81 617
47 645
184
4273
466
1
102
10
207
83 123
15
1 740 099
2
272
121
19 098
257 287
0
78
36
25
1470
7278
99
1868
130
6716
20
26
1541
12
185
0
16
5
1067
68 377
4342
583
139
40
55 842
426 675
100
567
100
101
100
100
171
100
101
100
100
100
84
100
100
100
100
102
100
100
101
94
99
171
101
100
100
99
100
17
45
90
91
86
96
73
50
74
70
85
69
90
27
84
75
75
80
41
81
81
68
70
90
87
65
15
3
3
0
83
0
5
26
14
9
2
3
0
65
4
36
0
0
17
8
2
77
19
5
2
4
9
6
3
1
8
11
4
5
13
10
8
5
9
5
4
3
25
5
6
0
4
3
1
17
7
18
3
2
0
0
0
1
0
9
4
1
0
1
0
0
4
0
0
1
1
1
0
5
1
1
1
2
2
1
6
6
0
4
2
9
2
9
5
4
4
1
0
20
19
5
4
6
4
0
2
2
7
33
1
1
0
0
4
6
4
3
5
0
0
2
4
13
0
6
3
11
1
2
3
2
2
0
1
0
0
2
0
0
0
0
0
2
0
2
4
0
0
0
0
55
6
0
11
0
0
0
0
0
0
1
100
82
60
93
94
86
83
96
78
76
88
79
88
72
90
92
87
75
36
75
80
58
88
82
77
87
75
92
91
166
10 127
0
324
2303
8
12 928
255
100
100
63
100
58
5
61
2
17
51
72
5
2
16
8
10
1
6
1
75
1
1
0
3
1
2
3
0
0
2
6
1
90
63
14
5
29
0
0
25
22
77
66
4
33
59
1
14
8
833
78 265
0
6
6
255
734
2
136
35
453
4
8
235
2
5
0
0
0
75
2963
3890
208
5
2
6011
94 156
0
29
25
80
82
50
0
67
49
100
46
74
37
50
0
51
100
0
23
57
67
0
80
100
80
80
100
57
13
7
6
0
83
11
23
0
7
11
25
25
50
20
0
60
24
19
2
70
20
0
6
7
0
7
0
6
3
17
17
5
14
0
14
6
13
0
38
6
0
20
11
5
2
20
0
0
5
3
0
0
0
3
3
0
0
11
5
0
3
0
0
0
0
11
0
0
4
6
2
0
0
0
5
3
0
7
0
2
2
33
0
3
3
0
8
0
12
25
13
7
0
0
29
9
7
7
0
0
2
3
0
0
13
1
1
0
0
4
7
0
4
6
4
0
0
3
0
0
7
3
20
1
0
0
3
2
0
0
50
0
3
0
0
0
0
0
0
17
3
8
0
0
0
0
20
0
0
0
3
0
0
1
0
0
0
2
100
86
38
87
89
50
83
78
72
100
54
86
63
75
50
72
100
60
47
76
69
70
100
100
85
87
65
10 127
0
324
3631
8
1249
6597
242
0
22 243
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American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
After default, DOTS
% of cohort
After failure, DOTS
% of cohort
Relapse, DOTS
Number
Regist'd
% of cohort
%
SuccessCured
Compl-
eted
Died Failed Default
Trans-
ferred
Not
eval.
1
14
8
754
0
6
6
233
734
2
86
29
351
3
4
146
2
5
0
0
0
75
2454
1608
180
5
2
5444
12 152
29
25
84
50
69
49
100
53
76
40
67
0
55
100
23
61
68
80
100
81
70
100
57
13
6
0
83
11
23
7
10
30
33
50
19
60
24
19
2
70
20
0
6
11
7
0
5
17
17
4
14
12
7
13
25
7
20
11
5
2
22
0
0
5
5
0
2
0
11
5
1
0
1
0
10
4
4
2
0
0
4
4
7
0
2
33
1
3
6
0
8
25
6
29
8
5
6
0
0
2
4
13
1
0
4
7
3
3
3
0
3
7
3
21
2
0
0
2
5
0
0
50
0
0
0
0
0
0
17
3
5
0
0
0
0
20
3
0
0
1
0
0
0
0
100
86
38
89
50
83
80
72
100
60
86
71
100
50
75
100
60
47
80
70
70
100
100
87
81
0
0
1
7
0
28
0
58
0
0
0
509
7
12
0
488
1110
0
29
18
45
39
71
60
47
100
0
14
26
19
83
7
14
0
29
11
3
7
7
7
0
29
0
17
16
17
16
0
0
21
5
16
8
5
10
0
0
4
3
4
29
4
4
0
14
32
0
0
0
8
0
1
100
29
32
71
58
71
83
66
62
0
0
21
43
6
74
1
4
31
0
0
0
330
16
0
79
605
52
35
67
30
0
45
62
87
56
0
9
17
7
50
16
4
63
8
8
14
16
12
50
10
1
19
1
5
14
2
0
0
10
1
0
1
19
14
31
100
0
16
18
19
4
17
0
7
17
11
0
3
15
0
10
0
16
0
9
0
0
0
0
0
0
2
52
44
83
36
50
61
66
63
95
64
Number
Regist'd
%
SuccessCured
Compl-
eted
Died Failed Default
Trans-
ferred
Not
eval.
Number
Regist'd
%
SuccessCured
Compl-
eted
Died Failed Default
Trans-
ferred
Not
eval.
TABLE 10: RE-TREATMENT OUTCOMES, 2003 COHORT
Not eval. — indicates not evaluated (percentage of registered cases for which outcomes were not recorded); success, sum of cured and completed; cases regist'd — the denominator for calculating treatment outcomes. The
number of cases registered for treatment in 2003 is used as the denominator for calculating treatment outcomes unless it is missing or is less than the sum of outcomes, in which case the sum of outcomes is used. Data can be
downloaded from http://stoptb.wpro.who.int.
19
Tuberculosis Control in the W
estern Pacific Region: 2006 Report
American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
DOTS new smear-positive treatment success (%)
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
DOTS new smear-positive case detection rate (%)
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
84
94
90
75
64
62
64
80
71
50
88
89
91
90
100
91
96
86
67
70
69
80
75
67
76
80
86
65
75
91
91
94
96
86
95
55
78
75
82
71
100
73
82
90
93
66
91
96
50
91
100
62
81
86
93
83
82
92
75
85
93
50
75
85
95
97
90
74
85
83
75
83
84
70
72
84
86
92
94
93
95
100
84
76
93
96
80
92
85
94
78
76
88
84
78
90
82
95
86
50
77
80
66
87
94
95
80
88
92
94
100
74
63
91
95
85
97
93
76
70
91
82
89
78
91
93
87
25
89
30
81
63
88
92
85
81
93
88
92
92
100
66
56
92
96
100
85
80
71
78
75
86
77
86
79
86
100
87
100
84
9
74
100
67
88
77
88
89
92
88
93
100
93
100
78
84
92
93
100
78
82
68
79
76
94
78
89
76
100
91
87
50
85
60
100
71
38
53
88
83
84
87
90
83
79
92
100
91
100
82
60
93
94
86
83
96
78
76
88
79
88
72
90
92
87
75
36
75
80
58
88
82
77
87
75
92
91
40
15
47
85
64
19
7
24
115
0
34
47
57
49
30
15
0
34
28
0
49
93
24
155
68
31
6
31
53
0
65
29
26
57
80
59
28
63
44
32
0
49
106
33
33
194
31
96
1
3
56
47
73
65
78
32
23
48
32
31
56
90
161
40
164
57
60
7
10
57
94
98
83
33
33
31
123
53
29
0
51
90
60
189
45
93
67
29
8
20
61
64
63
36
83
32
23
24
100
50
31
0
50
81
83
61
22
180
40
95
73
63
42
62
216
28
41
115
7
48
48
13
78
99
41
82
37
23
20
111
48
31
74
61
94
59
30
221
40
93
74
89
24
73
110
27
37
0
83
8
57
42
22
87
55
78
83
38
12
25
129
57
30
39
64
82
65
63
33
294
46
80
70
109
68
74
112
32
47
469
95
154
16
61
75
40
82
163
52
87
47
39
24
9
138
61
43
0
70
63
0
62
41
369
47
77
70
124
85
68
57
19
56
0
74
90
18
68
23
49
44
108
0
81
70
85
344
50
25
33
129
61
63
43
58
93
50
55
45
550
55
76
69
246
120
80
24
59
0
67
95
19
73
21
67
123
107
89
65
Treatment success — sum of cured and completed; DOTS new smear-positive case detection rate — notified (new and relapse) cases divided by estimated incident cases. The table includes updated information; data shown here
may differ from that published in previous reports. Data can be downloaded from http://stoptb.wpro.who.int.
TABLE 11: DOTS TREATMENT SUCCESS AND CASE DETECTION RATES, 1994-2004
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American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
Male Female All
Male/
female
ratio0–14 15–24 25–34 35–44 45–54 55–64 65+ 0-14 15-24 25-34 35-44 45-54 55-64 65+ 0-14 15-24 25-34 35-44 45-54 55-64 65+
0
0
36
1375
0
0
1
0
3
2
8
15
0
191
2
0
6
0
3
0
0
28
312
18
1
6
1
54
2062
18
10
850
35 465
0
8
1
0
59
193
17
122
8
1195
5
4
287
2
10
0
0
153
6792
709
12
11
7
3486
49 424
16
13
1466
43 594
0
6
2
1
94
462
10
182
7
2105
4
0
256
1
14
0
2
138
10 328
1278
32
12
11
7364
67 398
17
12
2261
45 408
0
8
3
2
128
599
12
234
18
2189
3
2
229
3
10
0
2
90
12 229
1365
56
8
2
9110
74 000
15
16
1942
46 256
0
6
0
6
226
934
10
318
31
1890
3
0
112
2
6
0
4
1
61
11 413
1249
84
11
6
8743
73 345
2
11
11
1759
41 846
0
7
1
2
175
1363
9
260
12
1440
2
2
54
1
5
0
1
2
43
7526
1020
75
9
3
5257
60 898
32
10
1538
50 797
1
2
4
3
477
3759
3
276
14
1535
1
43
2
16
0
0
6
4289
1604
120
5
5
8206
72 748
0
0
28
1659
0
0
0
6
6
7
12
0
227
1
3
18
0
0
0
0
30
291
26
0
10
3
66
2393
6
6
658
25 951
0
8
4
0
97
182
31
75
5
925
7
4
283
2
10
0
1
164
3507
662
6
22
5
1740
34 361
17
11
1276
25 150
0
6
6
1
112
364
9
137
7
1014
5
4
249
1
14
0
2
161
5090
848
15
20
8
2398
36 925
5
12
1882
20 613
0
3
1
2
87
230
12
155
12
852
3
1
162
0
4
0
1
1
66
5008
497
18
13
2
2218
31 860
1
7
8
2176
16 995
0
5
4
3
56
222
7
172
3
694
3
1
62
0
5
0
1
1
38
4327
343
17
14
2
2551
27 718
3
2
1836
14 038
0
2
2
1
34
294
6
165
2
605
0
3
24
1
1
0
0
18
3210
362
19
8
2
2226
22 864
19
4
1270
15 739
0
1
1
1
140
1,861
1
118
9
532
1
1
23
0
14
0
0
3
2183
1520
51
3
2
4970
28 467
0
0
64
3034
0
0
1
0
9
8
15
27
0
418
3
3
24
0
3
0
0
58
603
44
1
16
4
120
4 455
24
16
1508
61 416
0
16
5
0
156
375
48
197
13
2120
12
8
570
4
20
0
1
317
10 299
1371
18
33
12
5226
83 785
33
24
2742
68 744
0
12
8
2
206
826
19
319
14
3119
9
4
505
2
28
0
4
299
15 418
2126
47
32
19
9762
104 323
22
24
4143
66 021
0
11
4
4
215
829
24
389
30
3041
6
3
391
3
14
0
3
1
156
17 237
1862
74
21
4
11 328
105 860
1
22
24
4118
63 251
0
11
4
9
282
1156
17
490
34
2584
6
1
174
2
11
0
5
2
99
15 740
1592
101
25
8
11 294
101 063
2
14
13
3595
55 884
0
9
3
3
209
1657
15
425
14
2045
2
5
78
2
6
0
1
2
61
10 736
1382
94
17
5
7483
83 762
51
14
2808
66 536
1
3
5
4
617
5620
4
394
23
2067
1
2
66
2
30
0
0
9
6472
3124
171
8
7
13 176
101 215
2.0
1.9
1.7
1.1
2.2
1.5
0.7
1.8
2.2
2.3
0.9
1.7
2.4
2.2
1.0
0.5
1.2
2.8
1.3
1.8
1.5
1.1
2.2
1.7
3.0
0.7
1.5
2.6
2.2
For some countries, breakdown of notified cases by age and sex is missing, or is provided for only a subset of cases. Data can be downloaded from http://stoptb.wpro.who.int.
TABLE 12: NEW SMEAR-POSITIVE CASE NOTIFICATION BY AGE AND SEX, ABSOLUTE NUMBERS, DOTS AND NON-DOTS, 2004
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Male Female All
0–14 15–24 25–34 35–44 45–54 55–64 65+ 0–14 15–24 25–34 35–44 45–54 55–64 65+ 0–14 15–24 25–34 35–44 45–54 55–64 65+
American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
0
0
1
1
0
3
0
0
1
5
0
1
0
1
2
2
0
0
6
2
0
1
1
29
50
32
9
4
0
3
21
51
32
98
10
4
26
81
19
4
21
30
40
34
1
37
181
38
9
10
9
5
44
108
0
110
5
6
31
160
30
10
31
74
106
45
1
44
323
40
14
16
14
7
83
131
35
129
17
3
27
259
32
14
35
18
165
52
1
75
431
55
14
0
57
11
168
149
0
114
16
2
29
349
39
23
74
76
244
68
1
121
683
82
29
12
32
15
239
200
94
103
11
3
37
387
51
38
92
63
300
89
3
176
1080
114
13
69
60
36
283
296
57
100
31
8
8
312
97
75
73
140
400
116
0
0
1
1
0
0
0
1
6
15
4
0
0
3
2
1
0
10
7
1
1
0
19
39
25
10
17
0
3
13
42
34
98
11
4
31
43
19
2
46
23
21
25
1
29
155
23
9
32
9
4
33
53
52
109
5
5
36
80
21
5
55
53
34
26
0
45
237
19
5
6
18
3
52
52
17
90
0
1
20
106
12
4
55
17
39
23
1
50
387
21
12
32
33
3
86
56
22
61
0
2
19
129
11
5
94
26
69
27
0
36
498
29
8
27
19
3
132
86
137
44
13
1
17
160
17
10
86
46
119
34
1
70
457
30
6
16
19
13
104
88
46
41
0
5
4
127
63
27
45
58
207
37
0
0
1
1
0
1
0
0
1
5
7
3
0
0
2
2
0
0
8
5
0
1
1
24
45
29
10
10
0
3
17
47
33
98
10
4
28
62
19
3
33
27
31
29
1
33
168
31
9
21
9
4
39
81
27
110
5
6
34
120
25
8
42
64
70
36
1
45
277
30
10
11
16
5
67
92
26
109
9
2
23
183
22
9
45
17
101
38
1
65
407
39
13
15
46
7
126
103
11
87
8
2
24
238
25
14
84
52
155
48
1
89
574
56
18
19
26
9
181
144
116
73
12
2
28
271
33
24
89
55
207
62
2
123
668
68
9
42
39
23
187
184
51
67
15
6
6
209
77
49
60
100
296
73
Rates are per 100 000 population of each age/sex group. Rates are calculated excluding those countries for which breakdown of notified cases or population by age and sex is missing. Data can be downloaded from
http://stoptb.wpro.who.int.
TABLE 13: NEW SMEAR-POSITIVE CASE NOTIFICATION RATES BY AGE AND SEX, DOTS AND NON-DOTS, 2004
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From 1995, number shown is all notified new and relapse cases (DOTS and non-DOTS). The table includes updated information; data shown here may differ from that published in previous reports. Data can be downloaded from
http://stoptb.wpro.who.int.
TABLE 14: NUMBER OF TB CASES NOTIFIED, 1980-2004
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
2
1457
196
2576
0
37
210
76
55
8065
70 916
146
7630
1101
11 218
6
0
1160
0
108
474
1
0
17
2525
112 307
89 803
59
2710
266
0
64
33
178
43 062
23
356 481
6
1386
285
1980
10
180
66
41
7729
65 867
187
585
10 970
7
1094
2
128
448
0
26
10
2508
116 821
98 532
49
2425
313
1
49
18
92
43 506
24
355 345
6
1270
245
8158
98 654
19
163
65
49
7527
63 940
193
4706
233
11 944
12
67
1325
8
120
437
2
75
17
2742
104 715
100 878
43
2179
324
0
45
12
173
51 206
5
461 557
8
1219
276
7572
117 557
29
185
78
48
7301
62 021
127
4700
455
11 634
15
73
1514
0
171
415
3
74
14
2955
106 300
91 572
41
2065
302
0
50
23
196
43 185
17
462 195
12
1299
256
10 241
151 564
20
165
80
54
7843
61 521
111
6528
671
10 577
12
75
1652
0
144
404
1
58
20
3505
151 863
85 669
37
2143
337
0
54
9
188
43 875
14
541 002
5
1088
238
10 145
226 899
36
230
78
37
7545
58 567
103
4258
571
10 569
15
66
2994
0
104
359
0
64
26
3453
151 028
87 169
43
1952
377
2
49
32
124
46 941
14
615 181
8
906
212
10 325
265 095
17
199
85
49
7432
56 690
129
1514
420
10 735
37
60
2819
8
98
320
5
16
13
2877
153 129
88 789
65
1760
292
0
35
27
131
47 557
651 854
9
907
189
9106
251 600
16
173
80
34
7269
56 496
110
3468
389
11 068
32
98
2433
6
74
296
0
56
38
2251
163 740
87 419
29
1616
334
9
24
22
90
55 505
34
655 020
13
954
126
10 691
304 639
20
162
63
41
7021
54 357
208
7279
320
10 944
11
77
2538
8
111
295
3
27
17
4261
183 113
74 460
29
1666
372
1
14
24
118
52 463
1
716 447
5
952
128
7906
310 607
1
218
73
75
6704
53 112
121
2952
274
10 686
7
68
2233
0
128
303
28
3
3396
217 272
70 012
37
1617
488
0
36
26
144
52 270
30
741 912
9
1016
143
6501
375 481
1
226
59
6510
51 821
68
1826
343
11 702
367
1659
7
143
348
0
28
2497
317 008
63 904
44
1591
382
1
23
23
140
50 203
894 074
3
950
10 903
345 000
8
247
49
6283
50 612
91
1951
329
11 059
26
350
1611
140
335
6
3401
207 371
57 864
44
1841
309
1
20
30
230
59 784
22
760 870
1
1011
180
16 148
320 426
12
240
83
60
6534
48 956
100
994
294
11 420
52
111
1516
140
317
2
67
4
2540
236 172
48 070
26
1778
364
1
29
30
193
56 594
4
754 469
4
991
160
13 270
344 218
6
183
78
70
6 537
48 461
99
2093
285
12 285
61
151
1418
104
274
1
25
7451
178 134
46 999
49
1,830
367
33
28
114
52 994
11
718 784
4
1057
15 172
363 804
4
225
89
94
6319
44 425
253
1135
11 708
173
1730
4
97
352
2
46
41
5335
180 044
38 155
45
1677
332
0
23
19
152
51 763
11
724 290
1073
14 603
515 764
203
6212
43 078
830
402
11 778
172
2780
87
391
0
48
19
8041
119 186
42 117
45
1889
352
2
20
36
79
55 739
6
824 952
0
14 857
504 758
0
200
86
6501
42 122
327
1440
570
12 691
59
126
4062
104
352
2
51
5
3195
165 453
39 315
31
1951
299
0
22
126
74 711
8
873 424
6
1145
160
15 629
466 394
0
171
91
7 072
42 190
464
1923
575
13 539
107
3592
88
321
0
93
15
7977
195 767
33 215
32
1977
318
21
184
77 838
14
870 918
3
899
16 946
445 704
1
166
105
7673
44 016
276
2153
465
14 115
49
123
2915
90
365
0
97
11 291
162 360
34 661
22
2120
295
30
18
178
87 468
834 604
4
1073
272
19 266
449 518
3
192
93
5605
40 800
255
2434
14 908
41
3348
2
78
447
1
66
32
13 003
145 807
32 075
31
1805
289
0
22
14
120
88 879
820 483
3
1043
307
18 891
454 372
2
144
62
54
6015
39 384
252
2234
449
15 057
34
91
3109
4
94
344
0
75
10 520
119 914
21 782
43
1728
302
0
24
16
152
89 792
786 293
3
980
216
19 170
470 221
2
183
62
63
6788
35 489
189
2418
465
14 830
56
104
3526
3
61
377
0
58
12 658
107 133
37 268
22
1536
292
0
12
16
175
90 728
805 104
2
1013
230
24 610
462 609
1
148
64
51
6277
32 828
196
2621
388
14 389
51
127
3829
5
65
329
4
53
11
11 197
118 408
34 967
31
1516
256
29
13
101
95 044
19
811 482
3
949
206
28 216
615 868
0
185
50
22
5914
31 638
284
2766
371
15 671
60
99
3918
3
38
386
0
45
9
12 798
132 759
33 843
27
1581
293
0
16
30
104
92 741
15
980 908
5
1059
176
30 838
790 603
1
134
60
51
6143
29 736
310
3173
323
14 986
119
118
4570
61
373
0
53
5
12 743
130 530
34 671
1516
340
115
98 389
1 161 201
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
6
10
102
39
208
33
50
52
160
61
267
238
437
82
20
70
0
76
15
31
139
78
234
236
38
112
116
0
66
410
152
81
200
27
18
9
143
29
57
28
42
38
150
56
333
226
78
22
64
26
88
14
0
147
80
76
237
255
32
98
132
67
51
221
77
80
200
27
17
8
120
116
10
107
24
41
44
144
54
334
141
87
82
36
86
76
104
81
14
69
397
133
81
207
257
28
86
132
0
47
145
141
93
40
34
22
8
131
103
11
162
27
47
42
137
52
214
137
163
78
43
91
84
0
114
13
110
362
106
85
205
230
26
80
119
0
53
274
156
76
130
34
32
8
118
132
14
111
24
47
46
145
51
182
185
229
69
33
90
89
0
94
13
39
258
147
98
287
212
24
81
128
0
58
106
146
76
104
39
13
7
107
125
21
198
32
45
31
138
48
164
118
186
67
39
77
157
0
67
11
0
254
186
94
278
214
27
72
139
127
53
370
94
79
101
44
19
6
92
122
24
93
28
48
40
135
47
200
41
131
67
92
68
143
95
62
10
216
56
91
77
276
215
41
64
104
0
38
307
97
79
46
21
6
80
104
23
88
24
44
27
131
46
166
91
117
67
76
109
120
69
46
9
0
173
263
59
288
210
18
57
115
575
26
245
65
90
243
45
29
6
52
118
27
110
23
34
32
126
44
305
186
92
65
25
84
121
90
68
9
141
74
116
109
314
177
18
58
125
64
15
263
83
83
7
49
11
6
51
84
27
5
30
38
57
119
43
173
73
76
61
15
72
103
0
76
9
69
20
85
364
165
23
55
159
0
38
280
99
81
216
50
19
6
56
67
33
5
31
30
114
42
95
44
92
66
381
75
74
84
10
0
63
61
519
149
27
53
121
66
24
244
94
76
59
6
6
108
29
43
34
25
109
41
124
46
86
60
54
354
71
80
10
38
81
332
134
27
59
95
67
21
315
150
88
158
49
2
6
66
155
27
63
33
41
43
111
39
133
23
75
61
105
110
66
78
9
106
134
25
59
369
110
16
56
109
68
30
312
122
82
29
48
8
6
57
124
29
31
24
38
50
109
39
129
47
71
64
122
146
61
57
8
54
152
168
272
106
30
56
107
34
289
70
75
78
46
8
6
137
30
20
30
42
66
104
36
322
25
59
163
73
38
51
10
110
84
242
117
269
86
27
50
94
0
24
195
91
72
77
45
6
128
42
26
100
34
18
97
58
160
116
45
11
0
84
109
172
174
94
27
54
97
142
21
367
46
76
42
51
0
127
41
0
26
39
103
33
398
30
136
61
115
117
168
53
10
114
86
28
66
237
87
18
54
80
0
23
71
100
55
54
11
6
52
131
38
0
22
41
111
33
553
39
135
63
99
148
44
9
0
150
82
162
274
73
19
53
83
21
102
103
96
53
5
5
139
36
5
21
46
119
35
322
43
107
64
96
114
119
44
10
0
150
223
223
75
13
56
74
30
179
97
114
50
7
6
84
154
36
16
24
40
86
32
291
47
66
80
135
17
37
12
61
98
168
251
196
69
18
46
71
0
22
138
64
115
49
5
5
92
148
36
11
18
26
35
91
31
281
42
101
65
65
85
124
33
44
9
0
108
199
158
47
24
43
72
0
24
157
79
114
47
5
5
63
147
37
11
22
26
40
101
28
206
45
104
63
105
97
140
24
28
10
0
80
234
139
79
12
37
68
0
12
156
90
114
47
3
5
66
185
36
5
18
26
32
92
26
210
47
86
60
92
118
150
39
29
8
262
71
56
202
150
74
17
36
58
29
126
51
118
125
47
5
5
58
209
47
0
22
20
13
86
25
298
49
82
64
104
91
152
23
17
10
0
59
46
226
166
71
15
37
65
0
16
290
51
113
98
57
8
5
48
223
60
6
16
24
31
88
23
318
55
71
60
199
108
175
26
9
0
67
25
221
160
73
35
73
55
118
67
Rates are per 100 000 population. The table includes updated information; data shown here may differ from those published in previous reports. Data can be downloaded from http://stoptb.wpro.who.int
TABLE 15: CASE NOTIFICATION RATES, 1980-2004
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TABLE 16: NEW SMEAR-POSITIVE CASES NOTIFIED, NUMBERS AND RATES, 1993-2004
Number of cases
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong (China)
Japan
Kiribati
Lao People's Democratic Republic
Macao (China)
Malaysia
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Northern Mariana Islands
Palau
Papua New Guinea
Philippines
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific Region
1
557
68
84 898
4
58
2429
17 890
99
108
6954
12
0
16
91
0
8
92 279
16 630
21
513
155
16
2
222 809
4
11 058
104 729
1
0
38
40
16 770
184
6861
145
2
28
61
0
11
87 401
13 266
18
861
114
0
17
1
62
241 672
11 101
134 488
68
0
14 367
478
141
6688
9
455
21
78
0
14
9
1652
94 768
11 754
15
455
109
1
9
6
30
37 550
3
314 269
0
12 065
203 670
0
69
37
1774
12 867
144
886
258
7271
12
14
769
26
90
1
26
4
447
86 695
11 420
9
519
90
0
14
50
48 911
3
388 141
6
226
0
12 686
236 021
0
66
41
1943
13 571
50
1234
325
7496
9
1171
24
83
0
21
7
1195
80 163
9957
14
436
113
11
66
50 016
1
416 952
2
203
13 865
202 817
1
74
34
2091
11 935
52
1494
276
7802
11
14
1356
26
106
0
26
2107
69 476
10 359
7
482
140
16
38
54 889
379 699
3
285
102
15 744
201 775
0
65
33
1536
12 909
59
1719
8207
17
1513
2
22
94
1
15
20
2140
73 373
9559
17
465
93
0
10
0
43
53 805
383 626
2
251
84
14 822
204 765
0
62
29
43
1940
11 853
54
1526
160
8156
11
15
1389
4
20
74
0
27
1933
67 056
8216
13
248
109
0
15
0
63
53 169
376 109
2
228
95
14 361
204 591
2
73
0
47
1857
11 408
64
1563
157
8309
15
8
1631
2
19
68
0
19
1351
59 341
11 805
11
357
118
0
8
0
57
54 238
1
371 806
1
210
112
17 258
194 972
1
74
28
31
1892
10 807
82
1829
147
7958
18
22
1670
2
21
88
1
21
9
1345
65 148
11 345
19
549
108
23
0
38
56 811
1
372 641
2
113
121
18 923
267 414
0
78
21
0
1794
10 843
99
1868
138
7989
20
26
1541
1
12
106
0
16
5
2310
72 670
10 976
12
583
138
0
11
0
40
55 937
7
453 814
2
285
115
18 978
384 886
1
62
30
22
1694
10 471
142
2241
128
7843
39
35
1808
15
112
0
14
5
1896
78 163
11 501
506
152
59
58 389
579 594
Rate (per 100 000 population)
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
2
3
24
7
21
8
41
14
129
27
36
24
0
9
3
0
49
141
38
13
16
45
17
21
14
8
100
9
5
0
18
28
13
234
35
6
19
15
2
0
65
131
30
11
26
32
0
18
10
37
15
98
11
9
0
11
10
34
33
8
19
11
2
0
25
52
35
139
26
9
13
30
71
9
61
17
51
21
20
0
103
17
0
9
17
28
10
175
18
61
35
23
13
32
13
2
57
44
22
9
124
25
5
14
24
0
14
28
66
21
24
11
1
0
106
19
0
8
18
30
11
60
25
76
35
8
48
12
2
0
34
38
24
112
22
8
12
29
11
37
66
7
25
4
1
114
16
5
9
15
32
9
61
30
64
36
22
13
55
13
3
0
40
42
95
22
4
13
35
16
21
72
23
5
2
31
126
16
0
8
14
23
10
67
33
36
33
61
17
10
2
61
22
105
41
99
21
10
12
23
0
10
0
23
69
23
3
1
25
116
16
0
8
12
28
29
9
60
29
36
35
21
14
56
33
9
2
0
39
36
89
18
7
6
26
0
15
0
33
68
22
3
1
28
110
16
11
9
0
30
28
9
70
29
35
35
28
7
65
16
9
2
0
26
25
77
25
6
9
27
0
8
0
29
68
7
22
2
1
32
130
15
5
9
11
19
28
8
88
33
33
33
33
20
65
16
9
2
65
28
46
24
83
24
11
13
24
23
0
19
70
7
22
3
1
34
140
21
0
9
8
0
26
8
104
33
30
33
35
24
60
8
5
3
0
21
25
41
91
23
7
14
30
0
11
0
20
68
46
26
3
1
31
138
29
6
7
12
13
24
8
146
39
28
32
65
32
69
6
3
0
18
25
33
96
24
12
33
28
70
3325
Rates are per 100 000 population. The table includes updated information; data shown here may differ from those published in previous reports. Data can be downloaded from http://stoptb.wpro.who.int
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ANNEX 1. Definitions8
1. Definitions of tuberculosis cases
A case of tuberculosis: A patient in whom tuberculosis has been bacteriologically confirmed or
has been diagnosed by a clinician. Any person given treatment for tuberculosis should be recorded.
All types: The sum of new smear-positive pulmonary, relapse, new smear-negative pulmonary and
extrapulmonary cases.
New smear-positive pulmonary tuberculosis: A patient who has never received treatment for
tuberculosis, or who has taken anti-tuberculosis drugs for less than 30 days and who has one of
the following:
• two or more initial sputum smear examinations positive for acid fast bacilli (AFB);
• one sputum examination positive for AFB plus radiographic abnormalities consistent with
active pulmonary tuberculosis as determined by a clinician; or
• one sputum specimen positive for AFB and at least one sputum that is culture-positive for
AFB.
New smear-negative pulmonary tuberculosis: A case of pulmonary tuberculosis that does not
meet the above definition for smear-positive tuberculosis.
Extrapulmonary tuberculosis: Tuberculosis of organs other than the lungs, e.g. pleura, lymph
nodes, abdomen, genito-urinary tract, skin, joints, bones, meninges. Diagnosis should be based
on one culture-positive specimen, or histological or strong clinical evidence consistent with active
extrapulmonary tuberculosis, followed by a decision by a clinician to treat with a full course of anti-
tuberculosis chemotherapy. (A patient diagnosed with both pulmonary and extrapulmonary
tuberculosis should be classified as a case of pulmonary tuberculosis.)
Re-treatment case: Patient previously treated for tuberculosis, undergoing treatment for a new
episode of bacteriologically positive (sputum smear or culture) tuberculosis.
Relapse: A patient previously treated for tuberculosis and declared cured or treatment completed,
who is later diagnosed with bacteriologically positive (culture smear) tuberculosis.
2. Definitions of treatment outcome
Cured: Former smear-positive patient who was smear-negative in the last month of treatment, and
on at least one previous occasion.
Completed treatment: A patient who has completed treatment but who does not meet the criteria
to be classified either as a cure or a failure.
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Treatment success: The sum of patients who are cured and those who have completed treatment.
Died: A patient who dies for any reason during the course of treatment.
Failure: Smear-positive patient who remained smear-positive at five months or later during treatment.
Defaulted: A patient who has interrupted treatment for two consecutive months or more.
Transferred out: A patient who has been transferred to another recording and reporting unit and
for whom the treatment outcome is not known.
Not evaluated: A patient who did not have the treatment outcome evaluated.
Note: In countries where culture is current practice, patients can be classified as
cured or failed based on the culture results.
3. Indicators to assess treatment outcome
Cure rate: Proportion of cured cases out of all cases registered in a given period (2002, in this
report).
Treatment success rates: The sum of the proportion of patients who were cured and patients who
completed treatment out of all cases registered in a given period. The global target is an 85% cure
rate and a greater treatment success rate.
The cure rate and treatment success rate are expressed as a percentage of registered cases. The
number of new cases registered for treatment in 2003 (reported in 2004) is compared with the
number of cases notified as smear-positive in 2002 (reported in 2003). Differences may arise because
national TB control programmes (NTP) do not compile data at the end of each calendar year,
diagnosis may be incorrect, patients are lost between diagnosis and the start of treatment, or
records may be lost. All registered cases should be evaluated. Data on the six standard, mutually
exclusive outcomes of treatment are compiled. These figures are reported as percentages of all
registered cases, so that the possible outcomes plus the fraction of cases not evaluated add up to
100%. When a country states the number of patients registered for treatment, but gives no outcomes,
no result is reported, rather than reporting zero treatment success. Although treatment outcomes
are expressed as percentages, they are referred to as rates. The six possible outcomes plus the
fraction of cases not evaluated sum up to 100%. If the number of registered cases is lower than the
sum of the six outcomes or is missing, the denominator for treatment success will be the number
evaluated or the number of smear-positive cases notified in the previous year, whichever is greater.
4. Case detection rate and DOTS detection rate
DOTS
The recommended strategy for tuberculosis control is comprised of:
• Government commitment to ensuring sustained, comprehensive tuberculosis control
activities.
• Case detection by sputum smear microscopy among symptomatic patients self-reporting
to health services.
• Standardized short-course chemotherapy using regimens of six to eight months, for at
least all confirmed smear-positive cases. Good case management includes directly
observed treatment during the intensive phase for all new sputum smear-positive cases,
the continuation phase of rifampicin-containing regimens and the whole re-treatment
regimen.
• A regular, uninterrupted drug supply of all essential anti-tuberculosis drugs.
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• A standardized recording and reporting system that allows assessment of case-finding
and treatment results for each patient and of the tuberculosis control programme
performance overall.
Targets for tuberculosis control established by the World Health Assembly (1991)
• To cure 85% of the sputum smear-positive tuberculosis cases detected.
• To detect 70% of the estimated new sputum smear-positive tuberculosis cases.
Case notifications represent only a fraction of the true number of cases in a country because the
coverage by effective NTP may be incomplete.
The estimated case detection rate is defined as:
Case detection rate (%) =
DOTS detection rate refers to case detection under DOTS:
DOTS detection rate (%) =
The case detection rate and DOTS detection rate are identical when a country has a 100% DOTS
enrolment rate. Updated estimated incidence for 2003 used in this report was provided by WHO.
Population with access to DOTS: The country’s population that lives in administrative areas where
DOTS services are available.
DOTS enrolment rate (%): This rate indicates a proportion of cases enrolled in DOTS, out of
notified cases.
DOTS enrolment rate (all types) (%) =
DOTS enrolment rate (new SS+) (%) =
Annual new smear-positive notifications under DOTS
Estimated annual new smear-positive incidence (country)
Annual new smear-positive notifications (country)
Estimated annual new smear-positive incidence (country)
Annual notifications of all types under DOTS
Total annual notifications of all types
Annual notification of new SS+ under DOTS
Total annual notifications of new SS+
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ANNEX 2. Formulas for estimating tuberculosis incidence, prevalence
and deaths
Source: Corbett EL et al. The Growing Burden of Tuberculosis. Global Trends and Interactions with the HIV Epidemic.
Archives Internal Medicine, 2003, 163(9): 1009-1021.
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1. I = T/d and Is= Ts/ds N = Population
I = Incidence of TB (number of new cases
of TB per year
2. P = tl and Ps= tsls P = Prevalence of TB
3. Is/N = lk T = TB case notifications (per year)
D = Deaths from TB
4. D = fl and Ds= fls IRR = TB incidence rate ratio (TB incidence
rate in HIV-positive persons/TB incidence
in HIV-negative persons)
5. I = Ia
++Ia
-+In d = Proportion of cases notified (case
or detection rate)
I = ma
+ra
+Na
++ma
-ra
-Na
-+mnrnNn t = Average duration of TB disease (years)
l = Rate of infection with Mycobacterium
tuberculosis (MTB) (annual rate of infection
per person per year)
k = Ratio of incidence of smear-positive TB
to rate of MTB infection
6. IRR = ma
+ra
+/ma
-ra
-= (Ia
+/Na
+)/(Ia
-/Na
-) t = Proportion of TB patients who die from TB
(case fatality rate [CFR])
m = Prevalence of infection with MTB
7. Ia
+/Ia = IRR(Na
+/Na)/[1+(Na
+/Na)(IRR-1)] r = Rate of progression to TB disease in
MTB- infected individuals (per person per year)
s = Sputum smear-positive TB (no subscript
implies all forms)a = Adult (15–49 years old)
8. Ia
* = Ia
+-Ia
-Na
+/Na
- n = Other age groups (<15 or >49), assumed
HIV-uninfected
9. Da
* = Da
+-f - (I+-Ia
*) + = HIV-positive
- = HIV-negative
* = Attributable to HIV infection
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ANNEX 3. Statistical methods
Rates of change per year in the time series were assessed by estimating the slope of the log-
transformed rates against time.
The statistical analysis was carried out using the R language,9 available at no charge off the Internet.10
9 Ihaka R and Gentleman R. A language for data analysis and graphics. Journal of Computational and Graphical Statistics,
1996, 5(3): 299–314.
10 The R Project for Statistical Computing (http://www.r-project.org).
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